Evidence map›Paper›PMID 21283669›Full record

ArticlePloS one2011

Killing of targets by CD8 T cells in the mouse spleen follows the law of mass action.

Vitaly V Ganusov, Daniel L Barber, Rob J De Boer

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 47 citations in OpenAlex.

  1. Design principles of the cytotoxic CD8Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Design principles of the cytotoxic CD8bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Review
  6. Heterogeneity in killing efficacy of individual effector CD8Proceedings. Biological sciences · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Towards multiscale modeling of the CD8Wiley interdisciplinary reviews. Systems biology and medicine · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Vitaly V GanusovDepartment of Microbiology, University of Tennessee, Knoxville, Tennessee, United States of America.
Daniel L Barber
Rob J De Boer
National Institutes of Health · USUniversity of Tennessee at Knoxville · USUtrecht University · NL

Funding

Towards Mega-Throughput, Label-free Genomics and Proteomics: Revolutionizing MicrDP2OD006427 · OD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI OZCAN, AYDOGAN · 2009 to 2009
$2.3M
Lensfree On-Chip Near-field Microscopy based on Resonant Nano-AperturesR21EB009222 · NIBIB · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI OZCAN, AYDOGAN · 2008 to 2009
$330k
NIBIB NIH HHS 1R21EB009222-01NIH HHS DP2OD006427
6 · The paper itself

Abstract

It has been difficult to correlate the quality of CD8 T cell responses with protection against viral infections. To investigate the relationship between efficacy and magnitude of T cell responses, we quantify the rate at which individual CD8 effector and memory T cells kill target cells in the mouse spleen. Using mathematical modeling, we analyze recent data on the loss of target cells pulsed with three different peptides from the mouse lymphocytic choriomeningitis virus (LCMV) in mouse spleens with varying numbers of epitope-specific CD8 T cells. We find that the killing of targets follows the law of mass-action, i.e., the death rate of individual target cells remains proportional to the frequency (or the total number) of specific CD8 T cells in the spleen despite the fact that effector cell densities and effector to target ratios vary about a 1000-fold. The killing rate of LCMV-specific CD8 T cells is largely independent of T cell specificity and differentiation stage. Our results thus allow one to calculate the critical T cell concentration at which growth of a virus with a given replication rate can be prevented from the start of infection by memory CD8 T cell response.

Indexed as

Cytotoxicity, ImmunologicModels, ImmunologicalAnimalsCD8-Positive T-LymphocytesImmunologic MemoryLymphocytic choriomeningitis virusMiceSpleenT-Cell Antigen Receptor Specificity

Identifiers

PMID21283669
PMCPMC3025913
OpenAlexW1968094572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.